You are here: Industry Insights > Casma Therapeutics

News List

Casma Therapeutics raises $50m to support muscular dystrophy pharmaceutical-technology
September 14, 2020
US-based biotechnology company Casma Therapeutics has secured $50m in a Series B financing round to support the development of a programme targeting muscular dystrophy treatment.
Casma names Third Rock venture partner as COO fiercebiotech
December 27, 2018
Casma Therapeutics has named Third Rock Ventures’ Frank Gentile as its chief operating officer. The appointment means Gentile will commit full time to the autophagy startup he helped get off the ground......
Casma Therapeutics Announces Partnership with Fondazione Telethon, Founder of the Telethon Institute of Genetics and Medicine (TIGEM) pharmafocusasia
September 13, 2018
Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM),